MRI Technique for Detecting Cancer Could Replace Biopsies
By MedImaging International staff writers Posted on 06 Apr 2015 |
Image: Normal cells (left) have far more sugar attached to mucin proteins than do cancerous cells (right). Mucin-attached sugar generates a high MRI signal, shown in red (Photo courtesy of Xiaolei Song/Johns Hopkins Medicine).
A study suggests Magnetic Resonance Imaging (MRI) could be used for the noninvasive detection of cancer cells to complement or replace biopsies, without the need for injection of contrast dyes.
Researchers at Johns Hopkins School of Medicine (Baltimore, MD, USA) tested a technique that detects sugar molecules shed by the outer membranes of cancerous cells, so far only on lab-grown cells and mice.
The results of the study were published on online, in the journal Nature Communications on March 27, 2015.
Xiaolei Song, PhD, the lead author on the study, said, “This is the first time a property integral to cancer cells, rather than an injected dye, has been used to detect those cells. The advantage of detecting a molecule already inside the body is that we can potentially image the entire tumor. This often isn’t possible with injected dyes because they only reach part of the tumor. Plus, the dyes are expensive.
The team will next try to distinguish additional types of cancerous tumors from benign masses in live mice. If they succeed it could lead to earlier detection of cancer, new methods to monitor response to chemotherapy, and new ways to guide biopsies that may eventually make some biopsies unnecessary.
Related Links:
Johns Hopkins School of Medicine
Researchers at Johns Hopkins School of Medicine (Baltimore, MD, USA) tested a technique that detects sugar molecules shed by the outer membranes of cancerous cells, so far only on lab-grown cells and mice.
The results of the study were published on online, in the journal Nature Communications on March 27, 2015.
Xiaolei Song, PhD, the lead author on the study, said, “This is the first time a property integral to cancer cells, rather than an injected dye, has been used to detect those cells. The advantage of detecting a molecule already inside the body is that we can potentially image the entire tumor. This often isn’t possible with injected dyes because they only reach part of the tumor. Plus, the dyes are expensive.
The team will next try to distinguish additional types of cancerous tumors from benign masses in live mice. If they succeed it could lead to earlier detection of cancer, new methods to monitor response to chemotherapy, and new ways to guide biopsies that may eventually make some biopsies unnecessary.
Related Links:
Johns Hopkins School of Medicine
Latest MRI News
- Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
- World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer